Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir.

Yeon-Gu Choi, Hyeon Jeong Park, Sunmin Yim, Heun Joo Lee, Young Jun Choi, Won-Serk Kim, Ga-Young Lee
{"title":"Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir.","authors":"Yeon-Gu Choi,&nbsp;Hyeon Jeong Park,&nbsp;Sunmin Yim,&nbsp;Heun Joo Lee,&nbsp;Young Jun Choi,&nbsp;Won-Serk Kim,&nbsp;Ga-Young Lee","doi":"10.5021/ad.21.074","DOIUrl":null,"url":null,"abstract":"<p><p>Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"35 Suppl 1","pages":"S55-S58"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/c5/ad-35-S55.PMC10608398.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5021/ad.21.074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class.

Abstract Image

Abstract Image

Abstract Image

对阿昔洛韦无交叉反应的服用伐昔洛韦的患者的固定性药物爆发。
固定性药疹(FDE)是一种定义明确的色素沉着贴片,每次服用特定药物时都会在固定位置复发。FDE的常见病原体是非甾体抗炎药、非麻醉性镇痛药、镇静剂、抗惊厥药、磺酰胺和四环素。我们报告一名33岁男性,在服用伐昔洛韦两小时后,人中周围区域出现复发性、局限性、褐色至红斑的黄斑和丘疹。服用伐昔洛韦治疗单纯疱疹病毒感染的三次发作在同一部位引发了类似的皮疹。组织病理学结果显示表皮基底层空泡变性,色素失禁,乳头状真皮血管周围炎性细胞浸润。虽然斑贴试验和皮肤点刺试验显示对阿昔洛韦和伐昔洛韦呈阴性反应,但皮内试验显示仅对伐昔洛维呈阳性反应。阿昔洛韦和伐昔洛韦的口服激发试验显示,只有伐昔洛韦呈阳性反应。通过药物史、组织病理学检查、贴片试验、皮内试验和口服激发试验,我们最终诊断为缬昔洛韦引起的FDE,对阿昔洛韦没有交叉反应。为了寻找替代治疗药物,我们建议不仅对可疑药物进行诊断测试,还对同类药物进行诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信